Ori-Genic Biotech Corporation
Update：2026/08/06
Industries
Main Industry
Health Care
Main Product/Service
Pilatus Biosciences offers a unique opportunity to invest early at an attractive valuation. Our innovative therapies are already drawing strong interest from global pharmaceutical leaders, positioning us for high-value licensing deals or early M&A exits.
Founded Year
2021
Unified Business No.
91118204
Status
Active
Number of Employees
0
Total Paid-in
Capital
30,000,000 (NT$)
Location of Company
Taiwan
, Tainan City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Pilatus Biosciences, founded in 2022, pioneers first-in-class biologics targeting metabolic checkpoints to advance cancer immunotherapy. Drawing on groundbreaking research from the Ludwig Institute for Cancer Research (LICR) and the University of Lausanne
